Mark Davis

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Source:OMF

Mark M. Davis, PhD, is a Professor of Microbiology and Immunology and the Director of the Stanford Institute for Immunity, Transplantation and Infection at Stanford University School of Medicine.[1] He is on the ME/CFS Advisory Board of the Stanford ME/CFS Initiative.[2]

Education[edit | edit source]

  • Ph.D., Caltech, Molecular Biology (1981)
  • B.A., The Johns Hopkins University, Molecular Biology (1974)

ME/CFS research[edit | edit source]

Professor Mark Davis, along with Dr. Jose Montoya and many colleagues from several universities, are involved with the study of cytokines as a potential diagnostic biomarker of ME/CFS disease severity[3], as well as, differentiating between ME/CFS patients and sedentary controls.[4]

Notable studies on ME/CFS[edit | edit source]

Talks and interviews[edit | edit source]

Learn more[edit | edit source]

Mark Davis Stanford Bio

See also[edit | edit source]

References[edit | edit source]

  1. https://med.stanford.edu/profiles/mark-davis
  2. http://med.stanford.edu/chronicfatiguesyndrome/about/team.html
  3. Chronic fatigue syndrome research at Stanford - Stanford Medicine Spring 2016 - By: Kris Newby
  4. 4.0 4.1 Moneghetti, Kegan J.; Skhiri, Mehdi; Contrepois, Kévin; Kobayashi, Yukari; Maecker, Holden T.; Davis, Mark M.; Snyder, Michael; Haddad, Francois; Montoya, Jose G. (2018), "Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", Scientific Reports, 8, doi:10.1038/s41598-018-20941-w
  5. Montoya, Jose G.; Holmes, Tyson H.; Anderson, Jill N.; Maecker, Holden T.; Rosenberg-Hasson, Yael; Valencia, Ian J.; Chu, Lily; Younger, Jarred W.; Tato, Cristina M.; Davis, Mark M. (2017), "Cytokine signature associated with disease severity in chronic fatigue syndrome patients", Proceedings of the National Academy of Sciences of the United States of America, 114 (34): E7150-E7158, doi:10.1073/pnas.1710519114